- Home
- SGRP vs VNRX Comparison
SGRP vs VNRX Comparison
Compare SGRP & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- VNRX
- Stock Information
- Founded
- SGRP 1967
- VNRX N/A
- Country
- SGRP United States
- VNRX United States
- Employees
- SGRP N/A
- VNRX N/A
- Industry
- SGRP Business Services
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SGRP Consumer Discretionary
- VNRX Health Care
- Exchange
- SGRP Nasdaq
- VNRX Nasdaq
- Market Cap
- SGRP 52.3M
- VNRX 59.6M
- IPO Year
- SGRP 1996
- VNRX N/A
- Fundamental
- Price
- SGRP $1.83
- VNRX $0.63
- Analyst Decision
- SGRP
- VNRX Strong Buy
- Analyst Count
- SGRP 0
- VNRX 4
- Target Price
- SGRP N/A
- VNRX $4.17
- AVG Volume (30 Days)
- SGRP 70.6K
- VNRX 154.8K
- Earning Date
- SGRP 11-14-2024
- VNRX 11-14-2024
- Dividend Yield
- SGRP N/A
- VNRX N/A
- EPS Growth
- SGRP N/A
- VNRX N/A
- EPS
- SGRP 0.50
- VNRX N/A
- Revenue
- SGRP $228,869,000.00
- VNRX $1,285,827.00
- Revenue This Year
- SGRP N/A
- VNRX $71,446.31
- Revenue Next Year
- SGRP N/A
- VNRX N/A
- P/E Ratio
- SGRP $3.70
- VNRX N/A
- Revenue Growth
- SGRP N/A
- VNRX 97.50
- 52 Week Low
- SGRP $0.97
- VNRX $0.43
- 52 Week High
- SGRP $3.12
- VNRX $1.23
- Technical
- Relative Strength Index (RSI)
- SGRP 39.92
- VNRX 48.89
- Support Level
- SGRP $1.72
- VNRX $0.61
- Resistance Level
- SGRP $1.89
- VNRX $0.65
- Average True Range (ATR)
- SGRP 0.07
- VNRX 0.05
- MACD
- SGRP 0.00
- VNRX 0.00
- Stochastic Oscillator
- SGRP 42.31
- VNRX 38.10
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.